Kenji Hanyu

Multicentre, retrospective study of the efficacy and safety of nivolumab for recurrent and metastatic salivary gland carcinoma

Kazutomo Niwa, Daisuke Kawakita, Toshitaka Nagao et al. · Scientific Reports · 2020 · 56 citations · Full text

Effectiveness and safety of nivolumab in patients with head and neck cancer in Japanese real-world clinical practice: a multicenter retrospective clinical study

Nobuhiro Hanai, Yasushi Shimizu, Shin Kariya et al. · International Journal of Clinical Oncology · 2020 · 54 citations · Full text

Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma

Chihiro Fushimi, Isaku Okamoto, Takashi Matsuki et al. · Anticancer Research · 2020 · 36 citations · Full text

Real-World, Long-Term Outcomes of Nivolumab Therapy for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck and Impact of the Magnitude of Best Overall Response: A Retrospective Multicenter Study of 88 Patients

Takashi Matsuki, Isaku Okamoto, Chihiro Fushimi et al. · Cancers · 2020 · 26 citations · Full text

Neoadjuvant Therapy, Immunology, Pathology +16

Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study

Ryuji Yasumatsu, Yasushi Shimizu, Nobuhiro Hanai et al. · International Journal of Clinical Oncology · 2021 · 21 citations · Full text